Anti-VEGF and anti-Jagged treatments address (ii) and (iii) and could halt angiogenesis on a temporary basis, but do they not resolve the deterioration of Bruch’s membrane, which produces AMD. This evidence concerns the gene VEGFA and age-related macular degeneration.